Both proteasomes and lysosomes degrade the activated erythropoietin receptor
- 15 January 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (2) , 600-608
- https://doi.org/10.1182/blood-2004-03-1216
Abstract
Activation of the erythropoietin receptor (EpoR) after Epo binding is very transient because of the rapid activation of strong down-regulation mechanisms that quickly decrease Epo sensitivity of the cells. Among these down-regulation mechanisms, receptor internalization and degradation are probably the most efficient. Here, we show that the Epo receptor was rapidly ubiquitinated after ligand stimulation and that the C-terminal part of the Epo receptor was degraded by the proteasomes. Both ubiquitination and receptor degradation by the proteasomes occurred at the cell surface and required Janus kinase 2 (Jak2) activation. Moreover, Epo-EpoR complexes were rapidly internalized and targeted to the lysosomes for degradation. Neither Jak2 nor proteasome activities were required for internalization. In contrast, Jak2 activation was necessary for lysosome targeting of the Epo-EpoR complexes. Blocking Jak2 with the tyrphostin AG490 led to some recycling of internalized Epo-Epo receptor complexes to the cell surface. Thus, activated Epo receptors appear to be quickly degraded after ubiquitination by 2 proteolytic systems that proceed successively: the proteasomes remove part of the intracellular domain at the cell surface, and the lysosomes degrade the remaining part of the receptor-hormone complex. The efficiency of these processes probably explains the short duration of intracellular signaling activated by Epo.Keywords
This publication has 52 references indexed in Scilit:
- Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifsBlood, 2003
- Erythropoietin Receptors Associate with a Ubiquitin Ligase, p33RUL, and Require Its Activity for Erythropoietin-induced ProliferationPublished by Elsevier ,2003
- Molecular interpretation of ERK signal duration by immediate early gene productsNature Cell Biology, 2002
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- Growth Hormone Receptor Ubiquitination, Endocytosis, and Degradation Are Independent of Signal Transduction via Janus Kinase 2Published by Elsevier ,2001
- The Proteasome Regulates Receptor-mediated Endocytosis of Interleukin-2Journal of Biological Chemistry, 2001
- Proteasomes Regulate the Duration of Erythropoietin Receptor Activation by Controlling Down-regulation of Cell Surface ReceptorsJournal of Biological Chemistry, 2000
- Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor functionOncogene, 2000
- The Erythropoietin Receptor: Structure, Activation and Intracellular Signal TransductionTrends in Endocrinology & Metabolism, 1999
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996